Functional Brands to Acquire BullionFX | Alchemy Assets for $142.9M in Transformational All-Stock Deal
Summary
Functional Brands Inc. has signed a binding Letter of Intent to acquire BullionFX | Alchemy assets for $142.9 million in an all-stock deal, marking a significant strategic shift for the financially distressed company.
Key Events
-
Binding Letter of Intent Signed
Functional Brands Inc. entered into a binding Letter of Intent (LOI) on May 9, 2026, to acquire certain assets and intellectual property of BullionFX Ltd, including its Alchemy product, a blockchain-based infrastructure for gold-backed on-chain settlement.
-
Acquisition Valued at $142.9 Million
The Proposed Transaction is valued at an expected $142.9 million, to be paid in preferred stock of Functional Brands Inc. This value is exceptionally large compared to the company's current market capitalization.
-
All-Stock Deal with Potential for Massive Dilution
The preferred stock is expected to automatically convert into common stock upon shareholder approval and Nasdaq compliance, indicating a potential for massive dilution for current shareholders.
-
Strategic Pivot for Distressed Company
This acquisition represents a significant strategic shift from Functional Brands' traditional wellness products to a blockchain-based financial ecosystem, coming after the company disclosed a 'going concern' warning and is seeking a reverse stock split to avoid Nasdaq delisting.
Analysis
This acquisition represents a radical strategic pivot for Functional Brands, moving from wellness products to a blockchain-based financial ecosystem. Given the company's recent 'going concern' warning and efforts to avoid Nasdaq delisting, this high-value, all-stock transaction is a high-risk, high-reward attempt to redefine its future. The deal's value is vastly disproportionate to the company's current market capitalization, indicating a potentially massive dilution for existing shareholders if the preferred stock converts to common shares. The success of this transaction and subsequent integration will be critical for the company's survival and future valuation.
At the time of this filing, MEHA was trading at $0.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $0.08 to $8.00. This filing was assessed with neutral market sentiment and an importance score of 10 out of 10.